Changes in Dental Biofilm Proteins' Secondary Structure in Groups of People with Different Cariogenic Situations in the Oral Cavity and Using Medications by Means of Synchrotron FTIR-Microspectroscopy.

caries dental biofilm medicinal agent secondary structure of proteins synchrotron FTIR-microspectroscopy

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Oct 2023
Historique:
received: 15 09 2023
revised: 13 10 2023
accepted: 17 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

This work unveils the idea that the cariogenic status of the oral cavity (the presence of active caries lesions) can be predicted via a lineshape analysis of the infrared spectral signatures of the secondary structure of proteins in dental biofilms. These spectral signatures that work as natural markers also show strong sensitivity to the application in patients of a so-called modulator-a medicinal agent (a pelleted mineral complex with calcium glycerophosphate). For the first time, according to our knowledge, in terms of deconvolution of the complete spectral profile of the amide I and amide II bands, significant intra- and intergroup differences were determined in the secondary structure of proteins in the dental biofilm of patients with a healthy oral cavity and with a carious pathology. This allowed to conduct a mathematical assessment of the spectral shifts in proteins' secondary structure in connection with the cariogenic situation in the oral cavity and with an external modulation. It was shown that only for the component

Identifiants

pubmed: 37895003
pii: ijms242015324
doi: 10.3390/ijms242015324
pmc: PMC10607285
pii:
doi:

Substances chimiques

Amides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Science Foundation
ID : 23-15-00060

Références

Biotechnol Appl Biochem. 2000 Feb;31(1):41-53
pubmed: 10669401
Int J Biol Macromol. 2022 May 1;206:175-187
pubmed: 35217087
Clin Oral Investig. 2023 Mar;27(3):1123-1131
pubmed: 36121494
Front Cell Infect Microbiol. 2021 Jul 30;11:716493
pubmed: 34395316
Dent J (Basel). 2023 Apr 07;11(4):
pubmed: 37185477
IEEE Trans Biomed Eng. 2016 Feb;63(2):379-84
pubmed: 26208262
J Clin Pediatr Dent. 2003 Fall;28(1):47-52
pubmed: 14604142
Trends Microbiol. 2018 Mar;26(3):229-242
pubmed: 29097091
Int J Mol Sci. 2020 May 27;21(11):
pubmed: 32471277
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Mar 15;229:118006
pubmed: 31927236
Anal Chem. 2021 Jan 26;93(3):1561-1568
pubmed: 33332103
Biosens Bioelectron. 2014 Dec 15;62:13-8
pubmed: 24973537
J Med Life. 2012 Dec 15;5(4):390-7
pubmed: 23346239
Int J Oral Sci. 2021 Sep 30;13(1):30
pubmed: 34588414
EPMA J. 2018 Apr 25;9(2):195-203
pubmed: 29896318
Dent Mater. 1997 Jan;13(1):24-33
pubmed: 9467320
Caries Res. 2021;55(5):496-504
pubmed: 34517365
Pharmaceutics. 2022 Jun 26;14(7):
pubmed: 35890251
Front Physiol. 2017 Jun 29;8:450
pubmed: 28706493
Contemp Clin Dent. 2014 Apr;5(2):182-6
pubmed: 24963243
J Biophotonics. 2018 Mar;11(3):
pubmed: 28742273
Community Dent Oral Epidemiol. 2013 Feb;41(1):e41-52
pubmed: 24916677
Nat Commun. 2013;4:2890
pubmed: 24301518
Medicine (Baltimore). 2020 Feb;99(7):e19092
pubmed: 32049814
Eur Biophys J. 2021 May;50(3-4):641-651
pubmed: 33558954
Dis Markers. 2016;2016:1804727
pubmed: 28074077
Arch Oral Biol. 2012 Mar;57(3):264-70
pubmed: 21930261
Microorganisms. 2022 Dec 06;10(12):
pubmed: 36557666
Dent J (Basel). 2022 Sep 30;10(10):
pubmed: 36285994
Biochim Biophys Acta. 2007 Sep;1767(9):1073-101
pubmed: 17692815
J Am Dent Assoc. 2008 May;139 Suppl:25S-34S
pubmed: 18460677
Biomed Opt Express. 2019 Jul 17;10(8):4050-4058
pubmed: 31452994
Trends Biotechnol. 2006 Oct;24(10):455-62
pubmed: 16935373
J Dent Res. 2019 Apr;98(4):373-385
pubmed: 30890060
Braz Oral Res. 2017 Jun 05;31:e41
pubmed: 28591238
Int J Environ Res Public Health. 2022 Jul 15;19(14):
pubmed: 35886485
Curr Pharm Biotechnol. 2014;15(9):880-9
pubmed: 25307016
Molecules. 2015 Jul 10;20(7):12599-622
pubmed: 26184143
Acta Biochim Biophys Sin (Shanghai). 2007 Aug;39(8):549-59
pubmed: 17687489
Clin Oral Investig. 2014 Jul;18(6):1619-24
pubmed: 24240779
Sci Rep. 2019 Jun 27;9(1):9314
pubmed: 31249316
EPMA J. 2020 Aug 19;11(Suppl 1):1-133
pubmed: 32837665
Eur Biophys J. 2021 May;50(3-4):613-628
pubmed: 33534058
J Synchrotron Radiat. 2013 Sep;20(Pt 5):705-10
pubmed: 23955033
Eur J Orthod. 2004 Feb;26(1):25-30
pubmed: 14994879

Auteurs

Pavel Seredin (P)

Department of Solid-State Physics and Nanostructures, Voronezh State University, 394018 Voronezh, Russia.

Dmitry Goloshchapov (D)

Department of Solid-State Physics and Nanostructures, Voronezh State University, 394018 Voronezh, Russia.

Vladimir Kashkarov (V)

Department of Solid-State Physics and Nanostructures, Voronezh State University, 394018 Voronezh, Russia.

Anatoly Lukin (A)

Department of Solid-State Physics and Nanostructures, Voronezh State University, 394018 Voronezh, Russia.

Yaroslav Peshkov (Y)

Department of Solid-State Physics and Nanostructures, Voronezh State University, 394018 Voronezh, Russia.

Ivan Ippolitov (I)

Department of Pediatric Dentistry with Orthodontia, Voronezh State Medical University, 394006 Voronezh, Russia.

Yuri Ippolitov (Y)

Department of Pediatric Dentistry with Orthodontia, Voronezh State Medical University, 394006 Voronezh, Russia.

Tatiana Litvinova (T)

Computational Semasiology Laboratory, Voronezh State Pedagogical University, 394043 Voronezh, Russia.

Jitraporn Vongsvivut (J)

Australian Synchrotron (Synchrotron Light Source Australia Pty LTD), Clayton, VIC 3168, Australia.

Boknam Chae (B)

Pohang Accelerator Laboratory, Beamline Research Division, Pohang 37673, Republic of Korea.

Raul O Freitas (RO)

Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH